Child health and tuberculosis

The Lancet Respiratory Medicine

Volumn 2, Issue 4, 2014, Pages 254-256

  Marais, Ben J ^a   Schaaf, H Simon ^b   Graham, Stephen M ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

CHILD; CHILD HEALTH; CHILDHOOD MORTALITY; DRUG EFFICACY; HUMAN; INFECTION RISK; MOLECULAR EPIDEMIOLOGY; NOTE; PNEUMONIA; POVERTY; PRIORITY JOURNAL; PUBLIC HEALTH; RESPIRATORY TRACT DISEASE; SOCIAL ISOLATION; TUBERCULOSIS; TUBERCULOSIS CONTROL; CHILD WELFARE; HEALTH; MORTALITY;

CHILD; CHILD WELFARE; GLOBAL HEALTH; HUMANS; TUBERCULOSIS;

EID: 84897963366     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(14)70009-8     Document Type: Note

References (15)

1. Save the Children. Lives on the line: an agenda for ending preventable deaths.
2. Bates M, Mudenda V, Mwaba P, Zumla A Deaths due to respiratory tract infections in Africa: a review of autopsy studies. Curr Opin Pulm Med 2013, 19:229-237.
3. Liu L, Johnson HL, Cousens S, et al. Global, regional and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379:2151-2161.
4. Roadmap for childhood tuberculosis: towards zero deaths 2013, WHO, World Health Organisation, Geneva: Geneva, WHO/HTM/TB/2013.12 2013, (accessed Dec 18, 2013). http://apps.who.int/iris/bitstream/10665/89506/1/9789241506137_eng.pdf.
5. Global tuberculosis report 2013 2013, WHO, World Health Organisation, Geneva, (accessed Dec 18, 2013). http://www.who.int/tb/publications/global_report/en/index.html.
6. Marais BJ, Graham SM, Maeurer M, Zumla A Progress and challenges in childhood tuberculosis. Lancet Infect Dis 2013, 13:287-289.
7. Abubakar I, Ford N, Cox H, et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 2013, 13:529-539.
8. Shah NS, Yuen CM, Heo M, Tolman AW, Becerra MC Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis 2014, 58:381-391.
9. Marais BJ, Mlambo CK, Rastogi N, et al. Epidemic spread of multidrug-resistant (MDR) tuberculosis in Johannesburg, South Africa. J Clin Microbiol 2013, 51:1818-1825.
10. Zignol M, Sismanidis C, Falzon D, et al. Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J 2013, 42:701-707.
11. Ettehad D, Schaaf HS, Seddon J, et al. Treatment outcomes for children with multi-drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:449-456.
12. Donald PR, Ahmed A, Burman W, et al. Strategies for the clinical evaluation of new antituberculosis agents in children. Int J Tuberc Lung Dis 2013, 17:794-799.
13. van der Werf MJ, Langendam MW, Sandgren A, Manissero D Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews. Int J Tuberc Lung Dis 2012, 16:288-296.
14. Seddon JA, Hesseling AC, Finlayson H, et al. Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study. Clin Infect Dis 2013, 57:1676-1684.
15. Marais BJ, Lönnroth K, Lawn SD, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis 2013, 13:436-448.